Targeted contrast agents comprising a hydrazide functional group
申请人:RF Therapeutics Inc.
公开号:US10286090B2
公开(公告)日:2019-05-14
Described herein is a contrast agent for administration to a subject. The contrast agent includes a targeting portion that includes a hydrazide functional group; a metal ion bound to a metal-complexable portion; and a linker joining the targeting portion and the metal-complexable portion of the contrast agent. The portion that is not bound to a metal ion localizes the contrast agent to necrotic tissue in the subject.
A novel lanthanide probe was designed, synthesized, and employed for a sensitive and reliable assay of acrolein based on time-resolved luminescence measurement, which suppresses the background signal of serum.
TARGETED CONTRAST AGENTS COMPRISING A HYDRAZIDE FUNCTIONAL GROUP
申请人:RF Therapeutics Inc.
公开号:EP3229848B1
公开(公告)日:2020-08-12
[EN] TARGETED CONTRAST AGENTS COMPRISING A HYDRAZIDE FUNCTIONAL GROUP<br/>[FR] AGENTS DE CONTRASTE CIBLÉ COMPRENANT UN GROUPE FONCTIONNEL D'HYDRAZIDE
申请人:RF THERAPEUTICS INC
公开号:WO2016090491A1
公开(公告)日:2016-06-16
Described herein is a contrast agent for administration to a subject. The contrast agent includes a targeting portion that includes a hydrazide functional group; a metal ion bound to a metal-complexable portion; and a linker joining the targeting portion and the metal- complexable portion of the contrast agent. The portion that is not bound to a metal ion localizes the contrast agent to necrotic tissue in the subject.